Skip to main content
Jeffrey Gelfand, MD, Neurology, San Francisco, CA

Jeffrey Marc Gelfand MD

Neuroimmunology/Multiple Sclerosis


Associate Professor of Clinical Neurology, UCSF Department of Neurology, UCSF Neuroinflammation and MS Center

Join to view full profile
  • 505 Parnassus AveSan Francisco, CA 94143

  • Phone+1 415-476-1489

Dr. Gelfand is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurology, 2007 - 2010
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2028
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing  
    Luke Strnad, Leonard H Calabrese, John P Betjemann, Maulik P Shah, Felicia C Chow, Mark P Gorman, John E Greenlee, Michael R Wilson, Megan B Richie, Whitney Harrington..., JAMA

Authored Content

  • Risk of Neuroinflammatory Adverse Events with Tumor Necrosis Factor Inhibitor TreatmentMay 2020

Press Mentions

  • FSR Expands Scientific Advisory Board to Improve Research, Care
    FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024
  • Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis
    Allergy Drug Improves Function in Patients with Chronic Injury from Multiple SclerosisOctober 12th, 2017
  • Potential Prognostic Biomarker for Clinically Isolated Syndrome
    Potential Prognostic Biomarker for Clinically Isolated SyndromeJanuary 6th, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: